# A Clinical Trial of Multiple Formulations of MK-4082 in Healthy Overweight and Obese Participants (MK-4082-007)

> **NCT07748351** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 48 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** MK-4082 Formulation 1 (F1)
- **DRUG:** MK-4082 Formulation 2 (F2)
- **DRUG:** MK-4082 Formulation 4 (F4)

## Key facts

- **NCT ID:** NCT07748351
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2026-08-25
- **Primary completion:** 2026-12-15
- **Final completion:** 2026-12-15
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07748351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07748351, "A Clinical Trial of Multiple Formulations of MK-4082 in Healthy Overweight and Obese Participants (MK-4082-007)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07748351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*